Role of Activated Renin-Angiotensin System in Myocardial Fibrosis and Left Ventricular Diastolic Dysfunction in Diabetic Patients Reversal by Chronic Angiotensin II Type 1A Receptor Blockade

Background We attempted to test the hypothesis that chronic angiotensin II type 1A receptor blockade (ARB) alters myocardial collagen turnover leading to an improvement of diastolic dysfunction in diabetic patients. Methods and Results Forty-eight type 2 diabetic patients were divided into 2 groups:...

Full description

Saved in:
Bibliographic Details
Published inCirculation Journal Vol. 71; no. 4; pp. 524 - 529
Main Authors Kawasaki, Daizo, Kosugi, Keisuke, Waki, Hidehiko, Yamamoto, Kazuhiro, Tsujino, Takeshi, Masuyama, Tohru
Format Journal Article
LanguageEnglish
Published Japan The Japanese Circulation Society 2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background We attempted to test the hypothesis that chronic angiotensin II type 1A receptor blockade (ARB) alters myocardial collagen turnover leading to an improvement of diastolic dysfunction in diabetic patients. Methods and Results Forty-eight type 2 diabetic patients were divided into 2 groups: 38 treated with candesartan for 6 months, and 10 without candesartan, as controls. Doppler mitral flow velocity pattern and biomarkers of collagen type I turnover were assessed before and after ARB during a 6-month period. The mitral E/A ratio increased from 0.65±0.11 to 0.75±0.19. The carboxy-terminal propeptide of procollagen type I (PIP), an index of collagen type I synthesis, decreased and the carboxy-terminal telopeptide of collagen type I (CITP), an index of collagen type I degradation, increased following ARB. Consequently, the PIP/CITP ratio, an index of coupling between the synthesis and degradation of collagen type I, decreased. None of the indexes changed in the control group. The change in left ventricular chamber stiffness did not correlate with the change in PICP (r=0.08, p=NS), but it did with the changes in CITP or in the PIP/CITP ratio (r=0.35, p<0.05; r=0.39, p<0.05). Conclusions Chronic ARB improves diastolic dysfunction in diabetic patients, at least partially through the attenuation of myocardial fibrosis, by regulating collagen turnover, particularly by facilitating collagen degradation. (Circ J 2007; 71: 524 - 529)
AbstractList Background We attempted to test the hypothesis that chronic angiotensin II type 1A receptor blockade (ARB) alters myocardial collagen turnover leading to an improvement of diastolic dysfunction in diabetic patients. Methods and Results Forty-eight type 2 diabetic patients were divided into 2 groups: 38 treated with candesartan for 6 months, and 10 without candesartan, as controls. Doppler mitral flow velocity pattern and biomarkers of collagen type I turnover were assessed before and after ARB during a 6-month period. The mitral E/A ratio increased from 0.65±0.11 to 0.75±0.19. The carboxy-terminal propeptide of procollagen type I (PIP), an index of collagen type I synthesis, decreased and the carboxy-terminal telopeptide of collagen type I (CITP), an index of collagen type I degradation, increased following ARB. Consequently, the PIP/CITP ratio, an index of coupling between the synthesis and degradation of collagen type I, decreased. None of the indexes changed in the control group. The change in left ventricular chamber stiffness did not correlate with the change in PICP (r=0.08, p=NS), but it did with the changes in CITP or in the PIP/CITP ratio (r=0.35, p<0.05; r=0.39, p<0.05). Conclusions Chronic ARB improves diastolic dysfunction in diabetic patients, at least partially through the attenuation of myocardial fibrosis, by regulating collagen turnover, particularly by facilitating collagen degradation. (Circ J 2007; 71: 524 - 529)
BACKGROUNDWe attempted to test the hypothesis that chronic angiotensin II type 1A receptor blockade (ARB) alters myocardial collagen turnover leading to an improvement of diastolic dysfunction in diabetic patients. METHODS AND RESULTSForty-eight type 2 diabetic patients were divided into 2 groups: 38 treated with candesartan for 6 months, and 10 without candesartan, as controls. Doppler mitral flow velocity pattern and biomarkers of collagen type I turnover were assessed before and after ARB during a 6-month period. The mitral E/A ratio increased from 0.65+/-0.11 to 0.75+/-0.19. The carboxy-terminal propeptide of procollagen type I (PIP), an index of collagen type I synthesis, decreased and the carboxy-terminal telopeptide of collagen type I (CITP), an index of collagen type I degradation, increased following ARB. Consequently, the PIP/CITP ratio, an index of coupling between the synthesis and degradation of collagen type I, decreased. None of the indexes changed in the control group. The change in left ventricular chamber stiffness did not correlate with the change in PICP (r=0.08, p=NS), but it did with the changes in CITP or in the PIP/CITP ratio (r=0.35, p<0.05; r=0.39, p<0.05). CONCLUSIONSChronic ARB improves diastolic dysfunction in diabetic patients, at least partially through the attenuation of myocardial fibrosis, by regulating collagen turnover, particularly by facilitating collagen degradation.
We attempted to test the hypothesis that chronic angiotensin II type 1A receptor blockade (ARB) alters myocardial collagen turnover leading to an improvement of diastolic dysfunction in diabetic patients. Forty-eight type 2 diabetic patients were divided into 2 groups: 38 treated with candesartan for 6 months, and 10 without candesartan, as controls. Doppler mitral flow velocity pattern and biomarkers of collagen type I turnover were assessed before and after ARB during a 6-month period. The mitral E/A ratio increased from 0.65+/-0.11 to 0.75+/-0.19. The carboxy-terminal propeptide of procollagen type I (PIP), an index of collagen type I synthesis, decreased and the carboxy-terminal telopeptide of collagen type I (CITP), an index of collagen type I degradation, increased following ARB. Consequently, the PIP/CITP ratio, an index of coupling between the synthesis and degradation of collagen type I, decreased. None of the indexes changed in the control group. The change in left ventricular chamber stiffness did not correlate with the change in PICP (r=0.08, p=NS), but it did with the changes in CITP or in the PIP/CITP ratio (r=0.35, p<0.05; r=0.39, p<0.05). Chronic ARB improves diastolic dysfunction in diabetic patients, at least partially through the attenuation of myocardial fibrosis, by regulating collagen turnover, particularly by facilitating collagen degradation.
Author Yamamoto, Kazuhiro
Tsujino, Takeshi
Kawasaki, Daizo
Kosugi, Keisuke
Waki, Hidehiko
Masuyama, Tohru
Author_xml – sequence: 1
  fullname: Kawasaki, Daizo
  organization: Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine
– sequence: 2
  fullname: Kosugi, Keisuke
  organization: Osaka Police Hospital
– sequence: 3
  fullname: Waki, Hidehiko
  organization: Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine
– sequence: 4
  fullname: Yamamoto, Kazuhiro
  organization: Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine
– sequence: 5
  fullname: Tsujino, Takeshi
  organization: Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine
– sequence: 6
  fullname: Masuyama, Tohru
  organization: Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/17384453$$D View this record in MEDLINE/PubMed
BookMark eNpFkE1vGyEQhlGUKl_NLeeIU05dBxbYxUcrn5UctUqbXBHgIcFaQwJsJR_7z0tiq74Mo5lnHon3GO2HGAChM0omtBXs0vpkl5OeTkTL99ARZbxvuGzJ_mffNVPJ2SE6znlJSDslYnqADmnPJOeCHaG_j3EAHB2e2eL_6AIL_AjBh2YWXnwsELIP-Nc6F1jh2j2so9Vp4fWAb71JMfuMdVjgObiCnyGU5O046ISvvc4lDt7i63V2Y6j2GD4MdWGg1PlPXXw9yF_RF6eHDKfb9wQ93d78vrpv5j_uvl_N5o3lvSiNM53pLSGioy3twHZOGDDaCFmnhnHiGJPECmmktk5wa6dOyo6xru2t1JydoIuN9y3F9xFyUSufLQyDDhDHrHrCaNtyVsFvG9DW_-UETr0lv9JprShRH5Grz8hVT1WNvOLnW-9oVrDYwduMKzDbAMtc9Av8B3SqMQyws_FNqdLd7lUnBYH9A5a8mP4
CitedBy_id crossref_primary_10_1136_bmjopen_2015_010282
crossref_primary_10_3390_antiox12030679
crossref_primary_10_1253_circj_CJ_10_0024
crossref_primary_10_1161_CIRCULATIONAHA_109_912774
crossref_primary_10_1016_j_mam_2023_101194
crossref_primary_10_2217_bmm_2020_0298
crossref_primary_10_4236_wjcd_2013_35A005
crossref_primary_10_1038_hr_2013_119
crossref_primary_10_1248_bpb_33_1971
crossref_primary_10_1186_s12947_016_0050_y
crossref_primary_10_1007_s10554_011_9938_7
crossref_primary_10_1371_journal_pone_0022777
crossref_primary_10_1161_CIRCIMAGING_111_971606
crossref_primary_10_1177_1479164118819961
crossref_primary_10_1586_erc_10_17
crossref_primary_10_1007_s11892_009_0014_9
crossref_primary_10_1111_jdi_12153
crossref_primary_10_1007_s00380_008_1119_9
crossref_primary_10_1007_s10741_018_9749_1
crossref_primary_10_1016_j_diabres_2012_03_008
crossref_primary_10_1186_s13098_017_0219_z
crossref_primary_10_1111_eci_12673
crossref_primary_10_1253_circj_CJ_09_0046
crossref_primary_10_1016_j_ecl_2013_09_007
crossref_primary_10_1177_1753944709338489
crossref_primary_10_1253_circj_CJ_09_0324
crossref_primary_10_5625_lar_2012_28_2_99
crossref_primary_10_1016_j_addr_2021_113904
crossref_primary_10_1016_j_metabol_2009_01_009
crossref_primary_10_2337_dc08_0118
crossref_primary_10_3390_jcm3020566
crossref_primary_10_1254_jphs_08210FP
crossref_primary_10_1016_j_amjmed_2008_03_046
crossref_primary_10_1038_ki_2008_358
crossref_primary_10_1007_s10741_011_9257_z
crossref_primary_10_1016_j_phrs_2015_01_001
crossref_primary_10_1097_MD_0000000000021289
crossref_primary_10_1007_s11748_010_0597_8
crossref_primary_10_1016_j_amjcard_2009_05_015
Cites_doi 10.1161/01.CIR.91.5.1450
10.2337/diacare.17.7.633
10.1253/circj.70.995
10.1016/S0140-6736(03)14285-7
10.1038/labinvest.3780057
10.1161/01.CIR.104.3.286
10.1161/01.CIR.55.4.613
10.1161/01.CIR.0000017264.66561.3D
10.1016/S1262-3636(07)70059-9
10.1016/0735-1097(93)90735-J
10.2337/diacare.16.2.434
10.1161/hy1101.098549
10.1161/01.RES.64.6.1041
10.1161/01.CIR.0000125741.88712.77
10.1093/clinchem/39.11.2254
10.1161/01.CIR.102.12.1388
10.1253/circj.69.596
10.1016/0002-9149(74)90089-7
10.1016/S0735-1097(00)01064-0
10.2337/diacare.23.9.1316
10.1161/01.CIR.96.11.4065
10.1161/01.CIR.92.7.1933
10.1016/0735-1097(92)90318-H
10.1161/01.CIR.0000130845.38133.8F
10.1016/S0008-6363(02)00341-3
10.1161/01.CIR.0000140973.60992.9A
ContentType Journal Article
Copyright 2007 THE JAPANESE CIRCULATION SOCIETY
Copyright_xml – notice: 2007 THE JAPANESE CIRCULATION SOCIETY
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1253/circj.71.524
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1347-4820
EndPage 529
ExternalDocumentID 10_1253_circj_71_524
17384453
article_circj_71_4_71_4_524_article_char_en
Genre Randomized Controlled Trial
Journal Article
GroupedDBID ---
.55
.GJ
29B
2WC
3O-
53G
5GY
5RE
6J9
AAUGY
ACGFO
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
JSF
JSH
KQ8
M~E
OK1
P2P
RJT
RNS
RYR
RZJ
TKC
TR2
W2D
X7M
XSB
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c475t-fb6b7c00561216ec6f5bebab587c0b340f3380c58b8acf54cc9f88633627c8a43
ISSN 1346-9843
IngestDate Fri Aug 16 08:08:56 EDT 2024
Fri Aug 23 02:29:01 EDT 2024
Sat Sep 28 08:40:03 EDT 2024
Thu Aug 17 20:29:13 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c475t-fb6b7c00561216ec6f5bebab587c0b340f3380c58b8acf54cc9f88633627c8a43
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/circj/71/4/71_4_524/_article/-char/en
PMID 17384453
PQID 70312243
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_70312243
crossref_primary_10_1253_circj_71_524
pubmed_primary_17384453
jstage_primary_article_circj_71_4_71_4_524_article_char_en
PublicationCentury 2000
PublicationDate 2007-00-00
PublicationDateYYYYMMDD 2007-01-01
PublicationDate_xml – year: 2007
  text: 2007-00-00
PublicationDecade 2000
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Circulation Journal
PublicationTitleAlternate Circ J
PublicationYear 2007
Publisher The Japanese Circulation Society
Publisher_xml – name: The Japanese Circulation Society
References 2. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: The Framingham study. Am J Cardiol 1974; 34: 29-34.
25. Taniguchi I, Kawai M, Date T, Yoshida S, Seki S, Taniguchi M, et al. Effects of spironolactone during an angiotensin II receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophy. Circ J 2006; 70: 995-1000.
13. Lopez B, Gonzalez A, Varo N, Laviades C, Querejeta R, Diez J. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 2001; 38: 1222-1226.
20. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: A community-based study. Circulation 2004; 109: 3176-3181.
4. Cosson S, Kevorkian JP. Left ventricular diastolic dysfunction: An early sign of diabetic cardiomyopathy? Diabetes Metab 2003; 29: 455-466.
29. Linkhart SG, Linkhart TA, Taylor AK, Wergedal JE, Bettica P, Baylink J. Synthetic peptide-based immunoassay for amino-terminal propeptide of type I procollagen: Application for evaluation of bone formation. Clin Chem 1993; 39: 2254-2258.
27. Pitale SU, Abraira C, Emanuele NV, McCarren M, Henderson WG, Pacold I, et al. Two years of intensive glycemic control and left ventricular function in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM). Diabetes Care 2000; 23: 1316-1320.
12. Weber KT. Monitoring tissue repair and fibrosis from a distance. Circulation 1997; 96: 2488-2492.
10. Fiordaliso F, Li B, Latini R, Sonnenblick EH, Anversa P, Leri A, et al. Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II dependent. Lab Invest 2000; 80: 513-527.
22. Diez J, Querejeta R, Lopez B, Gonzalez A, Larman M, Martinez Ubago JL. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002; 105: 2512-2517.
24. Weber KT, Eghbali M. Collagen matrix synthesis and degradation in the development and regression of the left ventricular hypertrophy. Cardiovasc Rev Rep 1991; 12: 61-69.
8. Sakata Y, Masuyama T, Yamamoto K, Doi R, Mano T, Kuzuya T, et al. Renin angiotensin system-dependent hypertrophy as a contributor to heart failure in hypertensive rats: Different characteristics from renin angiotensin system-independent hypertrophy. J Am Coll Cardiol 2001; 37: 293-299.
14. Little WC, Ohno M, Kitzman DW, Thomas JD, Cheng CP. Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling. Circulation 1995; 92: 1933-1939.
21. Mori T, Hayashi T, Sohmiya K, Okuda N, Shimomura H, Ohkita M, et al. Mechanisms of combined treatment with celiprolol and candesartan for ventricular remodeling in experimental heart failure. Circ J 2005; 69: 596-602.
26. Fein FS, Miller-Green B, Zola B, Sonnenblick EH. Reversibility of diabetic cardiomyopathy with insulin in rabbits. Am J Physiol 1986; 250: H108-H113.
16. Blumsohn A, Herrington K, Hannon RA, Shao P, Eyre DR, Eastell R. The effect of calcium supplementation on the circadian rhythm of bone resorption. J Clin Endocrinol Metab 1994; 79: 730-735.
3. Regan TJ, Weisse AB. Diabetic cardiomyopathy. J Am Coll Cardiol 1992; 19: 1165-1166.
19. Nishimura RA, Schwartz RS, Holmes DR Jr, Tajik AJ. Failure of calcium channel blockers to improve ventricular relaxation in humans. J Am Coll Cardiol 1993; 21: 182-188.
5. Yamamoto K, Masuyama T, Sakata Y, Nishikawa N, Mano T, Yoshida J, et al. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. Cardiovasc Res 2002; 55: 76-82.
23. Querejeta R, Lopez B, Gonzalez A, Sanchez E, Larman M, Martinez Ubago JL, et al. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: Relation to myocardial fibrosis. Circulation 2004; 110: 1263-1268.
28. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, et al. CHARM Investigators and Committees: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial. Lancet 2003; 362: 777-781.
11. Lopez B, Querejeta R, Varo N, Gonzalez A, Larman M, Martinez Ubago JL, et al. Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation 2001; 104: 286-291.
7. Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 2000; 102: 1388-1393.
9. Sakata Y, Yamamoto K, Mano T, Nishikawa N, Yoshida J, Hori M, et al. Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: Its inhibition as a primary effect of Angiotensin-converting enzyme inhibitor. Circulation 2004; 109: 2143-2149.
17. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method. Circulation 1977; 55: 613-618.
1. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444.
6. Jalil JE, Doering CW, Janicki JS, Pick R, Shroff SG, Weber KT. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 1989; 64: 1041-1050.
18. Raev DC. Which LV function is impaired earlier in the evolution of diabetic cardiomyopathy?: An echocardiographic study of young type I diabetic patients. Diabetes Care 1994; 17: 633-639.
15. Diez J, Laviades C, Mayor G, Gil MJ, Monreal I. Increased serum concentrations of procollagen peptides in essential hypertension: Relation to cardiac alterations. Circulation 1995; 91: 1450-1456.
Raev DC (18) 1994; 17
22
23
Lopez B, Gonzalez A, Varo N, Laviad (13) 2001; 38
25
Diez J, Laviades C, Mayor G, Gil MJ (15) 1995; 91
28
Cosson S, Kevorkian JP (4) 2003; 29
Mori T, Hayashi T, Sohmiya K, Okuda (21) 2005; 69
Fiordaliso F, Li B, Latini R, Sonne (10) 2000; 80
Little WC, Ohno M, Kitzman DW, Thom (14) 1995; 92
Nishimura RA, Schwartz RS, Holmes D (19) 1993; 21
Regan TJ, Weisse AB (3) 1992; 19
Blumsohn A, Herrington K, Hannon RA (16) 1994; 79
Jalil JE, Doering CW, Janicki JS, P (6) 1989; 64
Stamler J, Vaccaro O, Neaton JD, We (1) 1993; 16
Weber KT (12) 1997; 96
Brilla CG, Funck RC, Rupp H (7) 2000; 102
Pitale SU, Abraira C, Emanuele NV (27) 2000; 23
Weber KT, Eghbali M (24) 1991; 12
2
5
Fein FS, Miller-Green B, Zola B, So (26) 1986; 250
Devereux RB, Reichek N (17) 1977; 55
8
Linkhart SG, Linkhart TA, Taylor AK (29) 1993; 39
9
Lopez B, Querejeta R, Varo N, Gonza (11) 2001; 104
20
References_xml – volume: 91
  start-page: 1450
  issn: 0009-7322
  year: 1995
  ident: 15
  publication-title: Circulation
  doi: 10.1161/01.CIR.91.5.1450
  contributor:
    fullname: Diez J, Laviades C, Mayor G, Gil MJ
– volume: 17
  start-page: 633
  issn: 0149-5992
  year: 1994
  ident: 18
  publication-title: Diabetes Care
  doi: 10.2337/diacare.17.7.633
  contributor:
    fullname: Raev DC
– ident: 25
  doi: 10.1253/circj.70.995
– ident: 28
  doi: 10.1016/S0140-6736(03)14285-7
– volume: 80
  start-page: 513
  issn: 0023-6837
  year: 2000
  ident: 10
  publication-title: Lab Invest
  doi: 10.1038/labinvest.3780057
  contributor:
    fullname: Fiordaliso F, Li B, Latini R, Sonne
– volume: 104
  start-page: 286
  issn: 0009-7322
  year: 2001
  ident: 11
  publication-title: Circulation
  doi: 10.1161/01.CIR.104.3.286
  contributor:
    fullname: Lopez B, Querejeta R, Varo N, Gonza
– volume: 55
  start-page: 613
  issn: 0009-7322
  year: 1977
  ident: 17
  publication-title: Circulation
  doi: 10.1161/01.CIR.55.4.613
  contributor:
    fullname: Devereux RB, Reichek N
– ident: 22
  doi: 10.1161/01.CIR.0000017264.66561.3D
– volume: 29
  start-page: 455
  issn: 1262-3636
  year: 2003
  ident: 4
  publication-title: Diabetes Metab
  doi: 10.1016/S1262-3636(07)70059-9
  contributor:
    fullname: Cosson S, Kevorkian JP
– volume: 21
  start-page: 182
  issn: 0735-1097
  year: 1993
  ident: 19
  publication-title: J Am Coll Cardiol
  doi: 10.1016/0735-1097(93)90735-J
  contributor:
    fullname: Nishimura RA, Schwartz RS, Holmes D
– volume: 12
  start-page: 61
  issn: 0197-3118
  year: 1991
  ident: 24
  publication-title: Cardiovasc Rev Rep
  contributor:
    fullname: Weber KT, Eghbali M
– volume: 16
  start-page: 434
  issn: 0149-5992
  year: 1993
  ident: 1
  publication-title: Diabetes Care
  doi: 10.2337/diacare.16.2.434
  contributor:
    fullname: Stamler J, Vaccaro O, Neaton JD, We
– volume: 38
  start-page: 1222
  issn: 0194-911X
  year: 2001
  ident: 13
  publication-title: Hypertension
  doi: 10.1161/hy1101.098549
  contributor:
    fullname: Lopez B, Gonzalez A, Varo N, Laviad
– volume: 64
  start-page: 1041
  issn: 0009-7330
  year: 1989
  ident: 6
  publication-title: Circ Res
  doi: 10.1161/01.RES.64.6.1041
  contributor:
    fullname: Jalil JE, Doering CW, Janicki JS, P
– ident: 9
  doi: 10.1161/01.CIR.0000125741.88712.77
– volume: 39
  start-page: 2254
  issn: 0009-9147
  year: 1993
  ident: 29
  publication-title: Clin Chem
  doi: 10.1093/clinchem/39.11.2254
  contributor:
    fullname: Linkhart SG, Linkhart TA, Taylor AK
– volume: 250
  start-page: H108
  issn: 0002-9505
  year: 1986
  ident: 26
  publication-title: Am J Physiol
  contributor:
    fullname: Fein FS, Miller-Green B, Zola B, So
– volume: 102
  start-page: 1388
  issn: 0009-7322
  year: 2000
  ident: 7
  publication-title: Circulation
  doi: 10.1161/01.CIR.102.12.1388
  contributor:
    fullname: Brilla CG, Funck RC, Rupp H
– volume: 69
  start-page: 596
  issn: 1346-9843
  year: 2005
  ident: 21
  publication-title: Circ J
  doi: 10.1253/circj.69.596
  contributor:
    fullname: Mori T, Hayashi T, Sohmiya K, Okuda
– ident: 2
  doi: 10.1016/0002-9149(74)90089-7
– ident: 8
  doi: 10.1016/S0735-1097(00)01064-0
– volume: 23
  start-page: 1316
  issn: 0149-5992
  year: 2000
  ident: 27
  publication-title: Diabetes Care
  doi: 10.2337/diacare.23.9.1316
  contributor:
    fullname: Pitale SU, Abraira C, Emanuele NV
– volume: 96
  start-page: 2488
  issn: 0009-7322
  year: 1997
  ident: 12
  publication-title: Circulation
  doi: 10.1161/01.CIR.96.11.4065
  contributor:
    fullname: Weber KT
– volume: 92
  start-page: 1933
  issn: 0009-7322
  year: 1995
  ident: 14
  publication-title: Circulation
  doi: 10.1161/01.CIR.92.7.1933
  contributor:
    fullname: Little WC, Ohno M, Kitzman DW, Thom
– volume: 19
  start-page: 1165
  issn: 0735-1097
  year: 1992
  ident: 3
  publication-title: J Am Coll Cardiol
  doi: 10.1016/0735-1097(92)90318-H
  contributor:
    fullname: Regan TJ, Weisse AB
– volume: 79
  start-page: 730
  issn: 0021-972X
  year: 1994
  ident: 16
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Blumsohn A, Herrington K, Hannon RA
– ident: 20
  doi: 10.1161/01.CIR.0000130845.38133.8F
– ident: 5
  doi: 10.1016/S0008-6363(02)00341-3
– ident: 23
  doi: 10.1161/01.CIR.0000140973.60992.9A
SSID ssj0029059
Score 2.05037
Snippet Background We attempted to test the hypothesis that chronic angiotensin II type 1A receptor blockade (ARB) alters myocardial collagen turnover leading to an...
We attempted to test the hypothesis that chronic angiotensin II type 1A receptor blockade (ARB) alters myocardial collagen turnover leading to an improvement...
BACKGROUNDWe attempted to test the hypothesis that chronic angiotensin II type 1A receptor blockade (ARB) alters myocardial collagen turnover leading to an...
SourceID proquest
crossref
pubmed
jstage
SourceType Aggregation Database
Index Database
Publisher
StartPage 524
SubjectTerms Aged
Angiotensin II Type 1 Receptor Blockers - pharmacology
Angiotensin II Type 1 Receptor Blockers - therapeutic use
Angiotensin II type 1A receptor blockade
Benzimidazoles - pharmacology
Benzimidazoles - therapeutic use
Blood Pressure - drug effects
Blood Pressure - physiology
Collagen
Collagen - metabolism
Diabetes Mellitus, Type 2 - physiopathology
Diastolic dysfunction
Endomyocardial Fibrosis - drug therapy
Endomyocardial Fibrosis - physiopathology
Female
Humans
Hypertension - physiopathology
Male
Middle Aged
Natriuretic Peptide, Brain - blood
Receptor, Angiotensin, Type 1 - drug effects
Renin-Angiotensin System - drug effects
Renin-Angiotensin System - physiology
Tetrazoles - pharmacology
Tetrazoles - therapeutic use
Ventricular Dysfunction, Left - drug therapy
Ventricular Dysfunction, Left - physiopathology
Subtitle Reversal by Chronic Angiotensin II Type 1A Receptor Blockade
Title Role of Activated Renin-Angiotensin System in Myocardial Fibrosis and Left Ventricular Diastolic Dysfunction in Diabetic Patients
URI https://www.jstage.jst.go.jp/article/circj/71/4/71_4_524/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/17384453
https://search.proquest.com/docview/70312243
Volume 71
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Circulation Journal, 2007, Vol.71(4), pp.524-529
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaghAXxLMs5eEDnFZZsrGdB7eFUroV5YBaVE6R7bXbdEWC9iHU_jh-GzOxk01pKxUuUeR48tB88Yztb2YIeQ0uvLTMiCAyqQh4xmQgwyQLmJJMhBMb6Qnu6O5_iXcP-d6ROFpb3-qwlpYLNdDnV8aV_I9WoQ30ilGy_6DZ9qbQAOegXziChuF4Ix1_9dTAka6LlBkMNSyLMhiVx0VVU9NLn5IclzX2z8BuzepAkR2YJFeYigSXzT8bu-h_w1XewpFStwsJLiFmv94-m6PhawiRjj6DZHqXjRVjTJDWAXdUmCXZldPpPn087uNMtz9E2h0yaKpZ_z3Yz6mcXEySUMy0LyTWJrO4LsMFusp7YOOxdma_K-gZqK0Nkb_kXE59JH1xXrUXqvny2LEYTDFfTlfbU773bjExJ8W0Ffguf0iAdOXoJ-fLk2JWXVguSTpjO-NxkKUuK9TANG1JwNMo7BoEVxPGA593Rnfhwr29oyDcUs0lGxTVhUQ0fP7pIBkOWqFuqu-_THBLjMQpGcjntXSeDHOQXie3oiQTWBji01HLX4qysK4E2H6Vj-oA6bfdZ1_wt26fwpTj2Fw_m6q9qoP75J6fDtGRw_YDsmbKh-TOvid8PCK_EeK0srSFOL0EceogTuFsBXHaQJwCxClCnHYgTluI0w7E8Q4NxGkDcdpAnKoz6iFOu08fjylCnA5HtIE4bSD-mBzufDz4sBv4kiOB5olYBFbFKtF1ftxoGBsdW6GMkkqk0KoYDy1jaahFqlKpreBaZzZNYwZuYKJTydkTslFWpXlKqLUaHFCVxlpwjlUerLI2kxkLNTdMDnvkTaOY_KfLLJNfpf4eeee01vby482qF3cH6Ly6diJnMET2yKtG0znYDdwMhL-zWs5zrFsB7jvrkU0HgNVLJCzlXLBnN3zBLXLXbXjguuRzsrGYLc0L8NQX6mWN2D-OVfeq
link.rule.ids 315,786,790,4043,27954,27955,27956
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+Activated+Renin-Angiotensin+System+in+Myocardial+Fibrosis+and+Left+Ventricular+Diastolic+Dysfunction+in+Diabetic+Patients+Reversal+by+Chronic+Angiotensin+II+Type+1A+Receptor+Blockade&rft.jtitle=Circulation+journal+%3A+official+journal+of+the+Japanese+Circulation+Society&rft.au=Kawasaki%2C+Daizo&rft.au=Kosugi%2C+Keisuke&rft.au=Waki%2C+Hidehiko&rft.au=Yamamoto%2C+Kazuhiro&rft.date=2007&rft.issn=1346-9843&rft.eissn=1347-4820&rft.volume=71&rft.issue=4&rft.spage=524&rft.epage=529&rft_id=info:doi/10.1253%2Fcircj.71.524&rft.externalDBID=n%2Fa&rft.externalDocID=10_1253_circj_71_524
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1346-9843&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1346-9843&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1346-9843&client=summon